Showing results (81-90 of 105) with videos related to
Sort By:
Pageof 11
Gynecologic Oncology|February 15, 2019
Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 studyStephan Polterauer, Richard Schwameis, Christoph Grimm, et al.Gynecologic Oncology|November 19, 2021
Adjuvant radiotherapy and local recurrence in vulvar cancer - a subset analysis of the AGO-CaRE-1 studyLinn Woelber, Katharina Prieske, Christine Zu Eulenburg, et al.Gynecologic Oncology|March 2, 2021
Age, treatment and prognosis of patients with squamous cell vulvar cancer (VSCC) - analysis of the AGO-CaRE-1 studyKatharina Prieske, Linn Woelber, Mustafa Zelal Muallem, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 26, 2017
European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar CancerMaaike H M Oonk, François Planchamp, Peter Baldwin, et al.Journal of Lower Genital Tract Disease|March 23, 2023
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) Consensus Statement on the Management of Vaginal Intraepithelial NeoplasiaVesna Kesic, Xavier Carcopino, Mario Preti, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 23, 2023
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus statement on the management of vaginal intraepithelial neoplasiaVesna Kesic, Xavier Carcopino, Mario Preti, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 21, 2022
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) consensus statements on pre-invasive vulvar lesionsMario Preti, Elmar Joura, Pedro Vieira-Baptista, et al.Journal of Lower Genital Tract Disease|June 28, 2022
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) Consensus Statements on Pre-invasive Vulvar LesionsMario Preti, Elmar Joura, Pedro Vieira-Baptista, et al.The Lancet. Oncology|April 12, 2021
Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 studyRobert L Coleman, Domenica Lorusso, Christine Gennigens, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 4, 2026
Evidence- and consensus-based guideline on lichen sclerosusGudula Kirtschig, Linn Woelber, Andreas Günthert, et al.Pageof 11